首页 > 最新文献

Hospital practice (1995)最新文献

英文 中文
Real-world data meta-analysis: procedural success and clinical outcomes after radiofrequency ablation of atrial fibrillation in South America. 真实世界数据荟萃分析:南美洲心房颤动射频消融后的手术成功和临床结果。
Q2 Medicine Pub Date : 2022-10-01 Epub Date: 2022-09-01 DOI: 10.1080/21548331.2022.2114721
Carlos Pablo Boissonnet, Mariano Aníbal Giorgi, Gastón Claudio Köhler, Luciano García Roura, Juan María Ginestar

Objective: To profile patients' characteristics, in-hospital results, and recurrence rates after radiofrequency ablation of atrial fibrillation (RAAF) in South America.

Methods: We comprehensively searched for single-center studies from South America with ≥10 patients receiving RAAF, published or presented from January 1, 2010, through June 29, 2020, excluding those reports aimed to specific populations such as permanent atrial fibrillation, structural cardiopathies, or re-do procedures.

Results: Main pooled estimates from a random-effects meta-analysis that included 3909 patients from 27 cohorts (from 5 countries): a) Patients characteristics: age 57.6 years (95% CI 55.7-59.5), male gender 71.5% (95% CI 67.0-75.6%), hypertension 54.2% (95% CI 45.4-62.8%), paroxysmal atrial fibrillation 79.8% (95% CI 71.3-94.5%), CHADS score 1.2 (95% CI 0.5-1.9), b) Acute procedural success 91.1% (95% CI 82.2-95.8%), c) In-hospital complications: stroke 0.6% (95% CI 0.3-1.2%), cardiac tamponade 2.3% (95% CI 1.4-3.7), hematoma 3.5% (95% CI 2.0-6.1), pseudoaneurysm 1.2% (95% CI 0.6-2.3), arteriovenous fistula 2.5% (95% CI 1.6-4.1). There were no cases of esophageal-atrial fistula nor death. Pooled estimate for arrhythmia recurrence (excluded 3-months blanking period) at 12 months was 19.9% (95% CI 17.0-23.1).

Conclusion: In-hospital results of RAAF reported for South American centers were worse than published international registries, even when included populations profile was of lower risk, as reflected in younger age and less prevalence of non-paroxysmal AF. Late recurrence rates seemed appropriate. This study provides a real-life framework for the analysis of the performance of this technology in the region.

目的:分析南美心房颤动(RAAF)射频消融后患者的特征、住院结果和复发率。方法:我们全面检索了2010年1月1日至2020年6月29日期间发表或发表的南美≥10例接受RAAF患者的单中心研究,排除了针对特定人群的报告,如永久性房颤、结构性心脏病或再做手术。结果:随机效应荟萃分析的主要汇总估计包括来自5个国家27个队列的3909例患者:a)患者特征:年龄57.6岁(95% CI 55.7-59.5),男性71.5% (95% CI 67.0-75.6%),高血压54.2% (95% CI 45.4-62.8%),阵发性房颤79.8% (95% CI 71.3-94.5%), CHADS评分1.2 (95% CI 0.5-1.9), b)急性手术成功率91.1% (95% CI 82.2-95.8%), c)院内并发症:脑卒中0.6% (95% CI 0.3-1.2%),心包填塞2.3% (95% CI 1.4-3.7),血肿3.5% (95% CI 2.0-6.1),假性动脉瘤1.2% (95% CI 0.6-2.3),动静脉瘘2.5% (95% CI 1.6-4.1)。无食管-房瘘发生,无死亡病例。12个月心律失常复发率(排除3个月空白期)的合并估计为19.9% (95% CI 17.0-23.1)。结论:南美中心报告的RAAF住院结果比国际上公布的登记结果更差,即使纳入的人群概况风险较低,反映在年龄较小和非阵发性房颤患病率较低。晚期复发率似乎是合适的。本研究为分析该地区该技术的性能提供了一个真实的框架。
{"title":"Real-world data meta-analysis: procedural success and clinical outcomes after radiofrequency ablation of atrial fibrillation in South America.","authors":"Carlos Pablo Boissonnet,&nbsp;Mariano Aníbal Giorgi,&nbsp;Gastón Claudio Köhler,&nbsp;Luciano García Roura,&nbsp;Juan María Ginestar","doi":"10.1080/21548331.2022.2114721","DOIUrl":"https://doi.org/10.1080/21548331.2022.2114721","url":null,"abstract":"<p><strong>Objective: </strong>To profile patients' characteristics, in-hospital results, and recurrence rates after radiofrequency ablation of atrial fibrillation (RAAF) in South America.</p><p><strong>Methods: </strong>We comprehensively searched for single-center studies from South America with ≥10 patients receiving RAAF, published or presented from January 1, 2010, through June 29, 2020, excluding those reports aimed to specific populations such as permanent atrial fibrillation, structural cardiopathies, or re-do procedures.</p><p><strong>Results: </strong>Main pooled estimates from a random-effects meta-analysis that included 3909 patients from 27 cohorts (from 5 countries): a) Patients characteristics: age 57.6 years (95% CI 55.7-59.5), male gender 71.5% (95% CI 67.0-75.6%), hypertension 54.2% (95% CI 45.4-62.8%), paroxysmal atrial fibrillation 79.8% (95% CI 71.3-94.5%), CHADS score 1.2 (95% CI 0.5-1.9), b) Acute procedural success 91.1% (95% CI 82.2-95.8%), c) In-hospital complications: stroke 0.6% (95% CI 0.3-1.2%), cardiac tamponade 2.3% (95% CI 1.4-3.7), hematoma 3.5% (95% CI 2.0-6.1), pseudoaneurysm 1.2% (95% CI 0.6-2.3), arteriovenous fistula 2.5% (95% CI 1.6-4.1). There were no cases of esophageal-atrial fistula nor death. Pooled estimate for arrhythmia recurrence (excluded 3-months blanking period) at 12 months was 19.9% (95% CI 17.0-23.1).</p><p><strong>Conclusion: </strong>In-hospital results of RAAF reported for South American centers were worse than published international registries, even when included populations profile was of lower risk, as reflected in younger age and less prevalence of non-paroxysmal AF. Late recurrence rates seemed appropriate. This study provides a real-life framework for the analysis of the performance of this technology in the region.</p>","PeriodicalId":35045,"journal":{"name":"Hospital practice (1995)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40334009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A questionnaire-based survey to assess knowledge and practice of health care workers regarding genital hygiene: from a rural tertiary hospital in India. 一项基于问卷的调查,以评估卫生保健工作者关于生殖器卫生的知识和做法:来自印度农村三级医院。
Q2 Medicine Pub Date : 2022-10-01 Epub Date: 2022-08-24 DOI: 10.1080/21548331.2022.2113657
P N Sreeramulu, A Varsha, Abhay K Kattepur, D Aswathappa

Purpose: Maintaining good genital hygiene is an important component in reducing human papilloma virus (HPV) infections and its sequelae such as cervical pre-cancer and cancer. Awareness on the exact practice of maintaining genital hygiene is important as they are different in men and women, and both are equally important in reducing genital HPV infections.

Study design: A questionnaire-based survey was undertaken to assess knowledge and practice of cervical cancer and its relationship with genital hygiene. Interns, post graduate students, consultants, and nurses were invited. Domain-based assessment was done. Correlation between the domains was performed using Pearson's coefficient.

Results: 87 respondents completed the questionnaire. Six domains on awareness of physical and genital hygiene, cervical cancer causation and prevention, health education and personal experience of cervical cancer were explored. In the awareness domains, the response was uniformly poor in 45-50% of respondents. Nurses had poor knowledge in every domain of the questionnaire.

Conclusions: There is an urgent need to improve and bridge the gap of knowledge and practice in hygiene and cervical cancer. This is necessary since nurses and interns are the first line for disseminating proper information to the general public. Webinars, seminars, and continued medical education (CME) programs must be included in the training curricula to impart knowledge on genital hygiene and cervical cancer.

目的:保持良好的生殖卫生是减少人乳头瘤病毒(HPV)感染及其后遗症(如宫颈癌前期和癌症)的重要组成部分。意识到保持生殖器卫生的确切做法很重要,因为男性和女性是不同的,两者在减少生殖器HPV感染方面同样重要。研究设计:以问卷为基础进行调查,以评估宫颈癌的知识和实践及其与生殖器卫生的关系。我们邀请了实习生、研究生、顾问和护士。完成了基于领域的评估。域之间的相关性使用Pearson系数进行。结果:87人完成问卷调查。探讨了身体和生殖卫生意识、宫颈癌的病因和预防、健康教育和宫颈癌的个人经历等六个领域。在意识领域,45-50%的受访者的反应都很差。护士对问卷各领域的了解程度较差。结论:卫生与宫颈癌知识与实践的差距亟待改善和弥合。这是必要的,因为护士和实习生是向公众传播适当信息的第一线。培训课程必须包括网络研讨会、研讨会和继续医学教育(CME)计划,以传授有关生殖器卫生和宫颈癌的知识。
{"title":"A questionnaire-based survey to assess knowledge and practice of health care workers regarding genital hygiene: from a rural tertiary hospital in India.","authors":"P N Sreeramulu,&nbsp;A Varsha,&nbsp;Abhay K Kattepur,&nbsp;D Aswathappa","doi":"10.1080/21548331.2022.2113657","DOIUrl":"https://doi.org/10.1080/21548331.2022.2113657","url":null,"abstract":"<p><strong>Purpose: </strong>Maintaining good genital hygiene is an important component in reducing human papilloma virus (HPV) infections and its sequelae such as cervical pre-cancer and cancer. Awareness on the exact practice of maintaining genital hygiene is important as they are different in men and women, and both are equally important in reducing genital HPV infections.</p><p><strong>Study design: </strong>A questionnaire-based survey was undertaken to assess knowledge and practice of cervical cancer and its relationship with genital hygiene. Interns, post graduate students, consultants, and nurses were invited. Domain-based assessment was done. Correlation between the domains was performed using Pearson's coefficient.</p><p><strong>Results: </strong>87 respondents completed the questionnaire. Six domains on awareness of physical and genital hygiene, cervical cancer causation and prevention, health education and personal experience of cervical cancer were explored. In the awareness domains, the response was uniformly poor in 45-50% of respondents. Nurses had poor knowledge in every domain of the questionnaire.</p><p><strong>Conclusions: </strong>There is an urgent need to improve and bridge the gap of knowledge and practice in hygiene and cervical cancer. This is necessary since nurses and interns are the first line for disseminating proper information to the general public. Webinars, seminars, and continued medical education (CME) programs must be included in the training curricula to impart knowledge on genital hygiene and cervical cancer.</p>","PeriodicalId":35045,"journal":{"name":"Hospital practice (1995)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40706118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of healthcare policy signals on patients' perceived value, trust and intention to use services offered by a healthcare provider. 医疗保健政策信号对患者感知价值、信任和使用医疗保健提供者提供的服务的意向的影响。
Q2 Medicine Pub Date : 2022-10-01 Epub Date: 2022-08-24 DOI: 10.1080/21548331.2022.2115776
Pei-Shan Hsieh, Fu-Ren Lin

Objective: Capitation is a healthcare reimbursement scheme in which a healthcare provider equitable access to funding for services and greater flexibility and budgeting. The objectives of the study are to investigate the effect of capitation signaling on patients' perceived value and trust and on their use intention.

Methods: This study was a scenario-based survey to examine interaction design, including capitation policy information and value-added health services information, which act as a combination of to test the hypotheses using signaling theory. Subject may receive the information about health services, information about a capitation policy, both of these two signals, or neither of them.

Results: The results of this study show that signal capitation policy and value-added health service information positively affects patients' perceived value, but not patients' trust. When a patient receives a signal either capitation policy information or value-added health service information, their perceived value, trust, and use intention are significantly higher than those who receive neither signal.

Conclusion: We suggest that high-quality healthcare institutions should consider distinguishing themselves from other low-quality providers by signaling information and allocate resources on value-added health services to enhance patients' awareness of healthy behavior and benefit from implementing a capitation payment scheme. This research contributes to healthcare stakeholders, especially policymakers and service providers, in terms of how best to engage with patients.

目标:人头制是一种医疗保健报销计划,在该计划中,医疗保健提供者公平获得服务资金,并具有更大的灵活性和预算编制。本研究的目的是探讨头戴信号对患者感知价值、信任和使用意愿的影响。方法:本研究采用基于场景的调查方法,考察交互设计,包括人均政策信息和增值卫生服务信息,它们作为组合,并使用信号理论检验假设。主体可以接收到有关健康服务的信息、有关人头政策的信息、这两个信号都接收到的信息,或者两者都不接收到。结果:本研究结果显示,信号化政策和医疗服务增值信息对患者感知价值有正向影响,对患者信任无正向影响。当患者接收到人头政策信息或增值医疗服务信息信号时,其感知价值、信任度和使用意愿显著高于未接收到信号的患者。结论:我们建议高质量的医疗机构应考虑通过信号信息和资源配置来区分其他低质量的医疗服务提供者,以提高患者的健康行为意识,并从实施人均支付计划中获益。这项研究有助于医疗保健利益相关者,特别是政策制定者和服务提供者,在如何最好地与患者接触方面。
{"title":"The effect of healthcare policy signals on patients' perceived value, trust and intention to use services offered by a healthcare provider.","authors":"Pei-Shan Hsieh,&nbsp;Fu-Ren Lin","doi":"10.1080/21548331.2022.2115776","DOIUrl":"https://doi.org/10.1080/21548331.2022.2115776","url":null,"abstract":"<p><strong>Objective: </strong>Capitation is a healthcare reimbursement scheme in which a healthcare provider equitable access to funding for services and greater flexibility and budgeting. The objectives of the study are to investigate the effect of capitation signaling on patients' perceived value and trust and on their use intention.</p><p><strong>Methods: </strong>This study was a scenario-based survey to examine interaction design, including capitation policy information and value-added health services information, which act as a combination of to test the hypotheses using signaling theory. Subject may receive the information about health services, information about a capitation policy, both of these two signals, or neither of them.</p><p><strong>Results: </strong>The results of this study show that signal capitation policy and value-added health service information positively affects patients' perceived value, but not patients' trust. When a patient receives a signal either capitation policy information or value-added health service information, their perceived value, trust, and use intention are significantly higher than those who receive neither signal.</p><p><strong>Conclusion: </strong>We suggest that high-quality healthcare institutions should consider distinguishing themselves from other low-quality providers by signaling information and allocate resources on value-added health services to enhance patients' awareness of healthy behavior and benefit from implementing a capitation payment scheme. This research contributes to healthcare stakeholders, especially policymakers and service providers, in terms of how best to engage with patients.</p>","PeriodicalId":35045,"journal":{"name":"Hospital practice (1995)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40622838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiotic treatment in patients with sepsis: a narrative review. 脓毒症患者的抗生素治疗:叙述性回顾。
Q2 Medicine Pub Date : 2022-08-01 Epub Date: 2020-07-20 DOI: 10.1080/21548331.2020.1791541
Erika P Plata-Menchaca, Ricard Ferrer, Juan Carlos Ruiz Rodríguez, Rui Morais, Pedro Póvoa

Sepsis is a medical emergency and life-threatening condition due to a dysregulated host response to infection, with unacceptably high morbidity and mortality. Similar to acute myocardial infarction or cerebral vascular accident, sepsis is a severe and continuous time-dependent condition. Thus, in the case of sepsis, early and adequate administration of antimicrobials must be a priority, ideally within the first hour of diagnosis, simultaneously with organ support.As a consequence of the emergence of multidrug-resistant pathogens, the choice of antimicrobials should be performed according to the local pathogen patterns of resistance. Individual antimicrobial optimization is essential to achieve adequate concentrations of antimicrobials, to reduce adverse effects, and to ensure successful outcomes, as well as preventing the emergence of multidrug-resistant pathogens. The loading dose is the administration of an initial higher dose of antimicrobials, regardless of the presence of organ dysfunction. Further doses should be implemented according to pharmacokinetics/pharmacodynamics of antimicrobials and should be adjusted according to the presence of renal or liver dysfunction. Extended or continuous infusion of beta-lactams and therapeutic drug monitoring can help to achieve therapeutic levels of antimicrobials. Duration and adequacy of treatment must be reviewed at regular intervals to allow effective de-escalation and administration of short courses of antimicrobials for most patients. Antimicrobial stewardship frameworks, leadership, focus on the optimal duration of treatments, de-escalation, and novel diagnostic stewardship approaches will help us to improve patients the process of care and overall quality of care.

脓毒症是一种医疗紧急和危及生命的疾病,由于宿主对感染的反应失调,具有不可接受的高发病率和死亡率。脓毒症与急性心肌梗死或脑血管意外相似,是一种严重且持续的时间依赖性疾病。因此,在败血症的情况下,必须优先考虑早期和适当的抗菌素管理,理想情况下在诊断后的第一个小时内,同时进行器官支持。由于出现多重耐药病原体,应根据当地病原体的耐药模式选择抗菌素。个别抗菌药物优化对于实现适当浓度的抗菌药物、减少不良反应、确保成功的结果以及防止出现多重耐药病原体至关重要。负荷剂量是指初始较高剂量的抗菌素,无论是否存在器官功能障碍。进一步的剂量应根据抗菌素的药代动力学/药效学实施,并应根据肾功能或肝功能障碍的存在进行调整。延长或持续输注β -内酰胺和治疗药物监测可帮助达到治疗水平的抗菌素。必须定期审查治疗的持续时间和适当性,以便对大多数患者有效降低剂量并给予短期抗菌药物治疗。抗菌药物管理框架、领导力、对最佳治疗持续时间的关注、降级和新的诊断管理方法将帮助我们改善患者的护理过程和整体护理质量。
{"title":"Antibiotic treatment in patients with sepsis: a narrative review.","authors":"Erika P Plata-Menchaca,&nbsp;Ricard Ferrer,&nbsp;Juan Carlos Ruiz Rodríguez,&nbsp;Rui Morais,&nbsp;Pedro Póvoa","doi":"10.1080/21548331.2020.1791541","DOIUrl":"https://doi.org/10.1080/21548331.2020.1791541","url":null,"abstract":"<p><p>Sepsis is a medical emergency and life-threatening condition due to a dysregulated host response to infection, with unacceptably high morbidity and mortality. Similar to acute myocardial infarction or cerebral vascular accident, sepsis is a severe and continuous time-dependent condition. Thus, in the case of sepsis, early and adequate administration of antimicrobials must be a priority, ideally within the first hour of diagnosis, simultaneously with organ support.As a consequence of the emergence of multidrug-resistant pathogens, the choice of antimicrobials should be performed according to the local pathogen patterns of resistance. Individual antimicrobial optimization is essential to achieve adequate concentrations of antimicrobials, to reduce adverse effects, and to ensure successful outcomes, as well as preventing the emergence of multidrug-resistant pathogens. The loading dose is the administration of an initial higher dose of antimicrobials, regardless of the presence of organ dysfunction. Further doses should be implemented according to pharmacokinetics/pharmacodynamics of antimicrobials and should be adjusted according to the presence of renal or liver dysfunction. Extended or continuous infusion of beta-lactams and therapeutic drug monitoring can help to achieve therapeutic levels of antimicrobials. Duration and adequacy of treatment must be reviewed at regular intervals to allow effective de-escalation and administration of short courses of antimicrobials for most patients. Antimicrobial stewardship frameworks, leadership, focus on the optimal duration of treatments, de-escalation, and novel diagnostic stewardship approaches will help us to improve patients the process of care and overall quality of care.</p>","PeriodicalId":35045,"journal":{"name":"Hospital practice (1995)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/21548331.2020.1791541","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38120886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Fever of unknown origin: evaluation of 110 classical and HIV-associated cases in the last decade. 不明原因发热:对过去十年110例典型和hiv相关病例的评估。
Q2 Medicine Pub Date : 2022-08-01 Epub Date: 2020-06-10 DOI: 10.1080/21548331.2020.1775453
Şemsi Nur Karabela, Kadriye Kart Yasar

Background: Fever is one of the critical symptoms of collagen vascular diseases, malignancies, and infectious diseases. Patients with a fever of unknown origin (FUO) were evaluated to determine the etiology.

Methods: In this study, 110 cases with FUO who were admitted to two hospitals with a total of 800 beds, in which 5000 daily outpatient patients were admitted between 2006 and 2016 have been evaluated retrospectively. Anamnesis and the findings were obtained from hospital records. Patients with a temperature higher than 38.3°C and lasting three weeks or longer without diagnosis despite one week of investigation in the hospital were included as FUO cases in this study. Nosocomial and neutropenic cases were excluded from the present study.

Results: Fifty-seven patients were male (52%), and the mean age was 40.2 ± 17.2. The distribution of the classic and HIV-associated cases was 85 (77.3%) and 18 (16.4%). Tuberculosis (TB) was the most frequent disease in both groups. The etiology was infectious in 68.2%, autoimmune in 14.5%, and neoplastic in 5.4%. There was no case of collagen vascular disease in the HIV-associated FUO group.

Conclusion: As a result of our study, infectious diseases and TB were still the leading factors that caused FUO. TB has been notably found higher in the HIV-associated group than the classic group. FUO is usually either a rare cause or an unusual clinical presentation of a well-known infectious disease in Turkey. Therefore, it should be noted that various manifestations of extra-pulmonary tuberculosis may be considered a FUO case.

背景:发热是胶原血管疾病、恶性肿瘤和感染性疾病的重要症状之一。对不明原因发热(FUO)患者进行评估以确定病因。方法:回顾性分析2006 - 2016年两所医院共800张床位收治的110例FUO患者,其中每日门诊患者5000例。从医院记录中获得记忆和结果。本研究将体温高于38.3℃且住院调查1周仍未确诊的患者纳入FUO病例。医院和中性粒细胞减少病例被排除在本研究之外。结果:男性57例(52%),平均年龄40.2±17.2岁。典型病例和hiv相关病例分别为85例(77.3%)和18例(16.4%)。结核病(TB)是两组中最常见的疾病。病因为感染性占68.2%,自身免疫性占14.5%,肿瘤占5.4%。在hiv相关的FUO组中没有胶原血管疾病的病例。结论:根据我们的研究结果,传染病和结核病仍然是导致FUO的主要因素。结核病在艾滋病毒相关组中的发病率明显高于经典组。在土耳其,FUO通常是一种众所周知的传染病的罕见病因或不寻常的临床表现。因此,应注意,肺外结核的各种表现可能被认为是FUO病例。
{"title":"Fever of unknown origin: evaluation of 110 classical and HIV-associated cases in the last decade.","authors":"Şemsi Nur Karabela,&nbsp;Kadriye Kart Yasar","doi":"10.1080/21548331.2020.1775453","DOIUrl":"https://doi.org/10.1080/21548331.2020.1775453","url":null,"abstract":"<p><strong>Background: </strong>Fever is one of the critical symptoms of collagen vascular diseases, malignancies, and infectious diseases. Patients with a fever of unknown origin (FUO) were evaluated to determine the etiology.</p><p><strong>Methods: </strong>In this study, 110 cases with FUO who were admitted to two hospitals with a total of 800 beds, in which 5000 daily outpatient patients were admitted between 2006 and 2016 have been evaluated retrospectively. Anamnesis and the findings were obtained from hospital records. Patients with a temperature higher than 38.3°C and lasting three weeks or longer without diagnosis despite one week of investigation in the hospital were included as FUO cases in this study. Nosocomial and neutropenic cases were excluded from the present study.</p><p><strong>Results: </strong>Fifty-seven patients were male (52%), and the mean age was 40.2 ± 17.2. The distribution of the classic and HIV-associated cases was 85 (77.3%) and 18 (16.4%). Tuberculosis (TB) was the most frequent disease in both groups. The etiology was infectious in 68.2%, autoimmune in 14.5%, and neoplastic in 5.4%. There was no case of collagen vascular disease in the HIV-associated FUO group.</p><p><strong>Conclusion: </strong>As a result of our study, infectious diseases and TB were still the leading factors that caused FUO. TB has been notably found higher in the HIV-associated group than the classic group. FUO is usually either a rare cause or an unusual clinical presentation of a well-known infectious disease in Turkey. Therefore, it should be noted that various manifestations of extra-pulmonary tuberculosis may be considered a FUO case.</p>","PeriodicalId":35045,"journal":{"name":"Hospital practice (1995)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/21548331.2020.1775453","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38028786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
A response to Zhou et al., regarding thiamine supplementation in altered mental status. 对Zhou等人关于补充硫胺素对改变精神状态的影响的回应。
Q2 Medicine Pub Date : 2022-08-01 DOI: 10.1080/21548331.2022.2036554
J Trebach, R S Hoffman
We read with interest the article by Zhou et al. entitled, ‘Thiamine supplementation in hospitalized patients with altered mental status: does it help?’ We applaud the authors for tackling the questions surrounding hospital use of thiamine and clinical outcomes, however, we have some concerns regarding their methodology and conclusions. This retrospective study examined patients who had altered their mental status and received thiamine. Because of the nonrandomized design, numerous potential confounders such as the varying etiologies of altered mental status, varying indications for treatment, polypharmacy, and so on, make comparisons questionable. Furthermore, there was a thiamine first group and a glucose first group. Again, because of design, we have no way of knowing if the patients who received glucose first were more sick, as acute hypoglycemia often presents more dramatically and emergently than thiamine deficiency. We respectfully disagree with the claim that the authors make about their patient population, saying that they believe it ‘will in general reflect those at all tertiary care centers’ – because we simply have no way of knowing this. Also, there is no insight as to how much thiamine patients received outside of ‘at least one dose.’ This is problematic because although there are no definitive-dose finding studies, respected resources recommend initial thiamine regimens for patients with Wernicke encephalopathy to be 500 mg IV (three times a day for up to 5 days) [1,2]. Furthermore, there is the issue of how thiamine was administered in this study. We caution the authors about drawing conclusions from the data in which patients received enteral thiamine. This is because the oral administration of thiamine is unpredictably absorbed and is not recommended in patients who have altered mental status due to thiamine deficiency [3]. Lastly, we take issue with the final line of the abstract. Saying that thiamine must be administered prior to glucose in altered mental status patients perpetuates a myth in medicine [4,5]. Thiamine uptake into cells and subsequent enzyme activation is slower than the uptake of glucose, so one could argue that it makes no difference whether you pretreat or post-treat with thiamine [6]. We again applaud the authors for undertaking this study and agree with their conclusion that there is a need to recognize the risks of Wernicke encephalopathy and provide supplemental thiamine.
{"title":"A response to Zhou et al., regarding thiamine supplementation in altered mental status.","authors":"J Trebach,&nbsp;R S Hoffman","doi":"10.1080/21548331.2022.2036554","DOIUrl":"https://doi.org/10.1080/21548331.2022.2036554","url":null,"abstract":"We read with interest the article by Zhou et al. entitled, ‘Thiamine supplementation in hospitalized patients with altered mental status: does it help?’ We applaud the authors for tackling the questions surrounding hospital use of thiamine and clinical outcomes, however, we have some concerns regarding their methodology and conclusions. This retrospective study examined patients who had altered their mental status and received thiamine. Because of the nonrandomized design, numerous potential confounders such as the varying etiologies of altered mental status, varying indications for treatment, polypharmacy, and so on, make comparisons questionable. Furthermore, there was a thiamine first group and a glucose first group. Again, because of design, we have no way of knowing if the patients who received glucose first were more sick, as acute hypoglycemia often presents more dramatically and emergently than thiamine deficiency. We respectfully disagree with the claim that the authors make about their patient population, saying that they believe it ‘will in general reflect those at all tertiary care centers’ – because we simply have no way of knowing this. Also, there is no insight as to how much thiamine patients received outside of ‘at least one dose.’ This is problematic because although there are no definitive-dose finding studies, respected resources recommend initial thiamine regimens for patients with Wernicke encephalopathy to be 500 mg IV (three times a day for up to 5 days) [1,2]. Furthermore, there is the issue of how thiamine was administered in this study. We caution the authors about drawing conclusions from the data in which patients received enteral thiamine. This is because the oral administration of thiamine is unpredictably absorbed and is not recommended in patients who have altered mental status due to thiamine deficiency [3]. Lastly, we take issue with the final line of the abstract. Saying that thiamine must be administered prior to glucose in altered mental status patients perpetuates a myth in medicine [4,5]. Thiamine uptake into cells and subsequent enzyme activation is slower than the uptake of glucose, so one could argue that it makes no difference whether you pretreat or post-treat with thiamine [6]. We again applaud the authors for undertaking this study and agree with their conclusion that there is a need to recognize the risks of Wernicke encephalopathy and provide supplemental thiamine.","PeriodicalId":35045,"journal":{"name":"Hospital practice (1995)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9565942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antihypertensive and cardioprotective effects of three generations of beta-adrenergic blockers: an historical perspective. 三代β -肾上腺素能阻滞剂的降压和心脏保护作用:一个历史的观点。
Q2 Medicine Pub Date : 2022-08-01 Epub Date: 2022-06-23 DOI: 10.1080/21548331.2022.2040920
Steven G Chrysant, George S Chrysant

There are currently three generations of beta-adrenergic blockers for the treatment of hypertension and cardiovascular diseases. The 1st generation caused vasoconstriction and bronchoconstriction due to β1 + β2 receptor blockade and unopposed α1 receptors. The 2nd generation of beta-blockers has lesser adverse effects than the 1st generation with the 3rd generation beta-blockers having much lesser effects than the other two generations. Current US and International guidelines do not recommend beta-blockers as first-line therapy of hypertension, but only in the presence of coronary artery disease or heart failure due to their lesser antihypertensive effect. These recommendations are disputed by several older and recent studies which have shown that the beta-blockers are effective and safe for the treatment of hypertension and could be used as first-line therapy. To clarify this issue a Medline search of the English language literature was conducted between 2012 and 2021 and 30 pertinent papers were selected. The data from these studies show that the beta-blockers have inferior antihypertensive and stroke protective effect compared with the other classes of antihypertensive drugs and should be used as first line therapy only in patients with hypertension associated with coronary artery disease or heart failure. The information from these papers and collateral literature will be discussed in this perspective.

目前有三代用于治疗高血压和心血管疾病的-肾上腺素能阻滞剂。第一代由于β1 + β2受体阻断和α1受体未对抗而引起血管收缩和支气管收缩。第二代受体阻滞剂的副作用比第一代小,第三代受体阻滞剂的副作用比其他两代小得多。目前美国和国际指南不推荐β -受体阻滞剂作为高血压的一线治疗,但仅在存在冠状动脉疾病或心力衰竭的情况下使用,因为它们的降压作用较小。这些建议受到一些较早和最近的研究的质疑,这些研究表明-受体阻滞剂对治疗高血压是有效和安全的,可以用作一线治疗。为了澄清这一问题,在2012年至2021年期间对英语文献进行了Medline检索,并选择了30篇相关论文。这些研究的数据表明,与其他类型的降压药物相比,受体阻滞剂的降压和卒中保护作用较差,仅应用于高血压合并冠状动脉疾病或心力衰竭患者的一线治疗。从这些论文和附属文献的信息将在这个角度进行讨论。
{"title":"Antihypertensive and cardioprotective effects of three generations of beta-adrenergic blockers: an historical perspective.","authors":"Steven G Chrysant,&nbsp;George S Chrysant","doi":"10.1080/21548331.2022.2040920","DOIUrl":"https://doi.org/10.1080/21548331.2022.2040920","url":null,"abstract":"<p><p>There are currently three generations of beta-adrenergic blockers for the treatment of hypertension and cardiovascular diseases. The 1<sup>st</sup> generation caused vasoconstriction and bronchoconstriction due to β<sub>1</sub> + β<sub>2</sub> receptor blockade and unopposed α<sub>1</sub> receptors. The 2<sup>nd</sup> generation of beta-blockers has lesser adverse effects than the 1<sup>st</sup> generation with the 3<sup>rd</sup> generation beta-blockers having much lesser effects than the other two generations. Current US and International guidelines do not recommend beta-blockers as first-line therapy of hypertension, but only in the presence of coronary artery disease or heart failure due to their lesser antihypertensive effect. These recommendations are disputed by several older and recent studies which have shown that the beta-blockers are effective and safe for the treatment of hypertension and could be used as first-line therapy. To clarify this issue a Medline search of the English language literature was conducted between 2012 and 2021 and 30 pertinent papers were selected. The data from these studies show that the beta-blockers have inferior antihypertensive and stroke protective effect compared with the other classes of antihypertensive drugs and should be used as first line therapy only in patients with hypertension associated with coronary artery disease or heart failure. The information from these papers and collateral literature will be discussed in this perspective.</p>","PeriodicalId":35045,"journal":{"name":"Hospital practice (1995)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39917458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Adult polyglucosan body disease: an acute presentation leading to unmasking of this rare disorder. 成人多葡聚糖体疾病:导致这种罕见疾病的急性表现。
Q2 Medicine Pub Date : 2022-08-01 Epub Date: 2021-01-27 DOI: 10.1080/21548331.2021.1874182
Jaspreet Johal, Ramiro Castro Apolo, Michael W Johnson, Michael R Persch, Adam Edwards, Preet Varade, Hussam Yacoub

Introduction: Adult polyglucosan body disease (APBD) is an autosomal recessive leukodystrophy caused by abnormal intracellular accumulation of glycogen byproducts. This disorder is linked to a deficiency in glycogen branching enzyme-1 (GBE-1). Neurologic manifestations include upper and lower motor neuron signs, dementia, and peripheral neuropathy. APBD is typically a progressive disease. In this report, we discuss a novel case of APBD in a patient who had a sudden onset of spastic quadriparesis preceded by gradual difficulty with gait. Genetic and postmortem analysis confirmed the diagnosis of APBD.

Case report: A 65-year-old man was evaluated for a new-onset of spastic quadriparesis, right-gaze preference, and left-sided beat nystagmus. Magnetic resonance imaging (MRI) of the brain revealed areas of white matter hyperintensities most prominent in the brainstem and periventricular regions. MRI of the cervical spine showed marked cord atrophy. Laboratory workup and cerebrospinal fluid analysis were unremarkable. Genetic testing supported the diagnosis of APBD due to GBE-1 deficiency. Postmortem analysis showed multiple white matter abnormalities suggestive of a leukodystrophy syndrome, and histopathologic testing revealed abnormal accumulation of polyglucosan bodies in samples from the patient's central nervous system supporting the diagnosis of APBD.

Conclusion: APBD is a rare disorder that can affect the nervous system. The diagnosis can be confirmed with a combination of genetic testing and pathologic analysis of affected brain tissue.

成人多葡聚糖体病(APBD)是一种常染色体隐性白质营养不良,由糖原副产物在细胞内异常积聚引起。这种疾病与糖原分支酶-1 (GBE-1)缺乏有关。神经系统表现包括上下运动神经元征象、痴呆和周围神经病变。APBD通常是一种进行性疾病。在这篇报道中,我们讨论了一个新的APBD病例,患者突然发作痉挛性四肢瘫,步态逐渐困难。遗传和尸检分析证实了APBD的诊断。病例报告:一名65岁男性被评估为新发痉挛性四肢瘫,右凝视偏好和左侧搏动眼球震颤。脑磁共振成像(MRI)显示脑干和脑室周围区域白质高信号最为突出。颈椎MRI显示脊髓明显萎缩。实验室检查和脑脊液分析无显著差异。基因检测支持GBE-1缺乏症导致APBD的诊断。尸检分析显示多发性白质异常提示脑白质营养不良综合征,组织病理学检查显示患者中枢神经系统样本中多葡聚糖体异常积聚,支持APBD的诊断。结论:APBD是一种少见的影响神经系统的疾病。诊断可以通过基因检测和受影响脑组织的病理分析相结合来证实。
{"title":"Adult polyglucosan body disease: an acute presentation leading to unmasking of this rare disorder.","authors":"Jaspreet Johal,&nbsp;Ramiro Castro Apolo,&nbsp;Michael W Johnson,&nbsp;Michael R Persch,&nbsp;Adam Edwards,&nbsp;Preet Varade,&nbsp;Hussam Yacoub","doi":"10.1080/21548331.2021.1874182","DOIUrl":"https://doi.org/10.1080/21548331.2021.1874182","url":null,"abstract":"<p><strong>Introduction: </strong>Adult polyglucosan body disease (APBD) is an autosomal recessive leukodystrophy caused by abnormal intracellular accumulation of glycogen byproducts. This disorder is linked to a deficiency in glycogen branching enzyme-1 (GBE-1). Neurologic manifestations include upper and lower motor neuron signs, dementia, and peripheral neuropathy. APBD is typically a progressive disease. In this report, we discuss a novel case of APBD in a patient who had a sudden onset of spastic quadriparesis preceded by gradual difficulty with gait. Genetic and postmortem analysis confirmed the diagnosis of APBD.</p><p><strong>Case report: </strong>A 65-year-old man was evaluated for a new-onset of spastic quadriparesis, right-gaze preference, and left-sided beat nystagmus. Magnetic resonance imaging (MRI) of the brain revealed areas of white matter hyperintensities most prominent in the brainstem and periventricular regions. MRI of the cervical spine showed marked cord atrophy. Laboratory workup and cerebrospinal fluid analysis were unremarkable. Genetic testing supported the diagnosis of APBD due to GBE-1 deficiency. Postmortem analysis showed multiple white matter abnormalities suggestive of a leukodystrophy syndrome, and histopathologic testing revealed abnormal accumulation of polyglucosan bodies in samples from the patient's central nervous system supporting the diagnosis of APBD.</p><p><strong>Conclusion: </strong>APBD is a rare disorder that can affect the nervous system. The diagnosis can be confirmed with a combination of genetic testing and pathologic analysis of affected brain tissue.</p>","PeriodicalId":35045,"journal":{"name":"Hospital practice (1995)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/21548331.2021.1874182","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39141515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Rapid establishment of a dedicated COVID-19 hospital in Mexico city during a public health crisis. 在公共卫生危机期间,在墨西哥城迅速建立了专门的COVID-19医院。
Q2 Medicine Pub Date : 2022-08-01 Epub Date: 2021-12-30 DOI: 10.1080/21548331.2021.2017644
Roberto Tapia-Conyer, Rafael Ricardo Valdez-Vázquez, Julieta Lomelín-Gascón, Rodrigo Saucedo-Martínez, Luis Alberto Martinez-Juarez, Héctor Gallardo-Rincón
ABSTRACT Healthcare systems worldwide have adapted and reorganized during the coronavirus disease 2019 (COVID-19) pandemic. Here, we provide a framework based on a public–private partnership that funded, developed, and operated a temporary COVID-19 hospital in Mexico City. We describe the creation of a collaborative network of primary healthcare triage centers and hospitals distributed throughout the city in recognition of demographic and geographic patterns that correlate with COVID-19 infections, including marginalized and impoverished areas of Mexico City. Additionally, we also report the hospital’s cumulative outcomes over the 14 months of operation and show that it is feasible to transform a large public venue into a specialized hospital that incorporates a digital platform with robust clinical protocols to provide positive clinical outcomes. PLAIN LANGUAGE SUMMARY During Mexico’s response to the COVID-19 pandemic, the Carlos Slim Foundation (CSF), with a group of local foundations, academic institutions, and the Government of Mexico City, established a synergistic public–private partnership with the purpose of funding, designing, developing, and operating a dedicated COVID-19 hospital. This was achieved in 17 days by rapidly transforming into a hospital the largest convention center in Latin America, which is located in the heart of Mexico City. An ex professo network of eight dedicated respiratory triage community centers in coordination with other 40 federal and state primary health care clinics and hospitals was also established to streamline patient referral, thereby mitigating the impact of the COVID-19 pandemic in Mexico City’s metropolitan area. We provide a framework for designing, funding, and executing the operations of a dedicated hospital in response to the COVID-19 pandemic that, from its conception, execution, operation, and closure, involved an exemplary coordination between public-private partnerships during a public health crisis. Referral, admission, treatment, clinical monitoring, discharge, and household follow-up were facilitated by the COVID360 digital health platform. The successful development and implementation of this multi-faceted digital platform allowed a lean patient-centered process, the management of clinical and administrative data, training of healthcare professionals, and the dissemination of accurate health information for data-driven decision making. This rapidly implemented temporary hospital dedicated to the comprehensive care of patients with COVID-19 was critical in coping with the increasing number of cases in Mexico City while achieving outstanding clinical outcomes.
在2019冠状病毒病(COVID-19)大流行期间,全球卫生保健系统进行了调整和重组。在此,我们提供了一个基于公私伙伴关系的框架,该框架资助、开发和运营了墨西哥城的一家临时COVID-19医院。我们描述了一个由分布在整个城市的初级卫生保健分诊中心和医院组成的协作网络的创建,以识别与COVID-19感染相关的人口和地理模式,包括墨西哥城的边缘化和贫困地区。此外,我们还报告了医院在14个月的运营中取得的累积成果,并表明将大型公共场所转变为专业医院是可行的,该医院采用了具有强大临床协议的数字平台,以提供积极的临床结果。
{"title":"Rapid establishment of a dedicated COVID-19 hospital in Mexico city during a public health crisis.","authors":"Roberto Tapia-Conyer,&nbsp;Rafael Ricardo Valdez-Vázquez,&nbsp;Julieta Lomelín-Gascón,&nbsp;Rodrigo Saucedo-Martínez,&nbsp;Luis Alberto Martinez-Juarez,&nbsp;Héctor Gallardo-Rincón","doi":"10.1080/21548331.2021.2017644","DOIUrl":"https://doi.org/10.1080/21548331.2021.2017644","url":null,"abstract":"ABSTRACT Healthcare systems worldwide have adapted and reorganized during the coronavirus disease 2019 (COVID-19) pandemic. Here, we provide a framework based on a public–private partnership that funded, developed, and operated a temporary COVID-19 hospital in Mexico City. We describe the creation of a collaborative network of primary healthcare triage centers and hospitals distributed throughout the city in recognition of demographic and geographic patterns that correlate with COVID-19 infections, including marginalized and impoverished areas of Mexico City. Additionally, we also report the hospital’s cumulative outcomes over the 14 months of operation and show that it is feasible to transform a large public venue into a specialized hospital that incorporates a digital platform with robust clinical protocols to provide positive clinical outcomes. PLAIN LANGUAGE SUMMARY During Mexico’s response to the COVID-19 pandemic, the Carlos Slim Foundation (CSF), with a group of local foundations, academic institutions, and the Government of Mexico City, established a synergistic public–private partnership with the purpose of funding, designing, developing, and operating a dedicated COVID-19 hospital. This was achieved in 17 days by rapidly transforming into a hospital the largest convention center in Latin America, which is located in the heart of Mexico City. An ex professo network of eight dedicated respiratory triage community centers in coordination with other 40 federal and state primary health care clinics and hospitals was also established to streamline patient referral, thereby mitigating the impact of the COVID-19 pandemic in Mexico City’s metropolitan area. We provide a framework for designing, funding, and executing the operations of a dedicated hospital in response to the COVID-19 pandemic that, from its conception, execution, operation, and closure, involved an exemplary coordination between public-private partnerships during a public health crisis. Referral, admission, treatment, clinical monitoring, discharge, and household follow-up were facilitated by the COVID360 digital health platform. The successful development and implementation of this multi-faceted digital platform allowed a lean patient-centered process, the management of clinical and administrative data, training of healthcare professionals, and the dissemination of accurate health information for data-driven decision making. This rapidly implemented temporary hospital dedicated to the comprehensive care of patients with COVID-19 was critical in coping with the increasing number of cases in Mexico City while achieving outstanding clinical outcomes.","PeriodicalId":35045,"journal":{"name":"Hospital practice (1995)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39805175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A web-based point prevalence survey of antimicrobial use and quality indicators at Raleigh Fitkin Memorial Hospital in the Kingdom of Eswatini and the implications. 斯瓦蒂尼王国罗利·菲特金纪念医院抗菌药物使用和质量指标的网络点流行率调查及其影响。
Q2 Medicine Pub Date : 2022-08-01 DOI: 10.1080/21548331.2022.2069247
Prudence C Gwebu, Johanna C Meyer, Natalie Schellack, Zinhle C Matsebula-Myeni, Brian Godman

Objectives: Currently there is limited knowledge regarding antimicrobial utilization patterns among public hospitals in Eswatini. This is a concern given rising resistance rates among African countries. This study aimed to address this by determining antimicrobial utilization patterns using a point prevalence survey (PPS) methodology at Raleigh Fitkin Memorial (RFM) Hospital. The findings would be used to identify potential interventions to improve future antimicrobial utilization.

Method: A PPS was conducted using a web-based application (App). Antimicrobials were categorized according to the World Health Organization (WHO) Access, Watch, and Reserve (AWaRe) classification. Each ward in the hospital was surveyed in one day using patient files. All patients in the ward, admitted by 08h30 on the day of the survey, were included. Ethical clearance was granted by the university and at country level.

Results: Overall, 68 patient files in 12 wards were surveyed, with 88.2% (60/68) receiving at least one antimicrobial. The most widely prescribed antimicrobials were amoxicillin (24.3%), and ceftriaxone IV (21.6%), mostly from the Access group (69.9%), and zero from the Reserve group. In the past 90 days prior to admission, most patients (60.3%; 41/68) were not receiving any antimicrobials. Of concern was that antimicrobial use was empirical for all patients (100%) with mostly parenteral administration (88.3%; 91/103). In addition, the majority of surgical prophylaxis patients (80%; 12/15) were given an extended course post surgery. There was also no documented switch or stop dates, or patient culture and drug sensitivity results.

Conclusion: Antimicrobial utilization is high at RFM hospital. Identified targets for quality improvement programs include encouraging earlier switching to oral antimicrobials, reducing extended use for surgical prophylaxis and encouraging greater sensitivity testing and documentation stop dates. The development of the App appreciably reduced data collection times and analysis, and would be recommended for use in other public hospitals.

目的:目前,关于斯威士兰公立医院抗菌药物使用模式的知识有限。鉴于非洲国家的耐药性不断上升,这是一个令人担忧的问题。本研究旨在通过在罗利菲特金纪念医院(RFM)使用点流行调查(PPS)方法确定抗菌药物的使用模式来解决这一问题。研究结果将用于确定潜在的干预措施,以提高未来抗菌药物的使用。方法:采用基于web的应用程序(App)进行PPS。根据世界卫生组织(WHO)获取、观察和储备(AWaRe)分类对抗菌素进行分类。利用病人档案在一天内对医院的每个病房进行了调查。调查当天08:30前入院的所有患者均被纳入。大学和国家都批准了道德许可。结果:共调查了12个病房的68例患者档案,88.2%(60/68)患者接受了至少一种抗菌药物治疗。最广泛使用的抗菌药是阿莫西林(24.3%)和头孢曲松IV(21.6%),主要来自无障碍组(69.9%),而储备组为零。入院前90天内,大多数患者(60.3%;41/68)未接受任何抗微生物药物治疗。值得关注的是,所有患者的抗菌药物使用都是经验性的(100%),主要是肠外给药(88.3%;91/103)。此外,大多数手术预防患者(80%;12/15)术后给予延长疗程。也没有记录切换或停止日期,或患者培养和药物敏感性结果。结论:RFM医院抗菌药物使用率较高。已确定的质量改进方案目标包括鼓励尽早改用口服抗菌素,减少外科预防的延长使用,鼓励进行更严格的敏感性检测和记录停止使用日期。该应用程序的开发大大减少了数据收集和分析的时间,建议在其他公立医院使用。
{"title":"A web-based point prevalence survey of antimicrobial use and quality indicators at Raleigh Fitkin Memorial Hospital in the Kingdom of Eswatini and the implications.","authors":"Prudence C Gwebu,&nbsp;Johanna C Meyer,&nbsp;Natalie Schellack,&nbsp;Zinhle C Matsebula-Myeni,&nbsp;Brian Godman","doi":"10.1080/21548331.2022.2069247","DOIUrl":"https://doi.org/10.1080/21548331.2022.2069247","url":null,"abstract":"<p><strong>Objectives: </strong>Currently there is limited knowledge regarding antimicrobial utilization patterns among public hospitals in Eswatini. This is a concern given rising resistance rates among African countries. This study aimed to address this by determining antimicrobial utilization patterns using a point prevalence survey (PPS) methodology at Raleigh Fitkin Memorial (RFM) Hospital. The findings would be used to identify potential interventions to improve future antimicrobial utilization.</p><p><strong>Method: </strong>A PPS was conducted using a web-based application (App). Antimicrobials were categorized according to the World Health Organization (WHO) Access, Watch, and Reserve (AWaRe) classification. Each ward in the hospital was surveyed in one day using patient files. All patients in the ward, admitted by 08h30 on the day of the survey, were included. Ethical clearance was granted by the university and at country level.</p><p><strong>Results: </strong>Overall, 68 patient files in 12 wards were surveyed, with 88.2% (60/68) receiving at least one antimicrobial. The most widely prescribed antimicrobials were amoxicillin (24.3%), and ceftriaxone IV (21.6%), mostly from the Access group (69.9%), and zero from the Reserve group. In the past 90 days prior to admission, most patients (60.3%; 41/68) were not receiving any antimicrobials. Of concern was that antimicrobial use was empirical for all patients (100%) with mostly parenteral administration (88.3%; 91/103). In addition, the majority of surgical prophylaxis patients (80%; 12/15) were given an extended course post surgery. There was also no documented switch or stop dates, or patient culture and drug sensitivity results.</p><p><strong>Conclusion: </strong>Antimicrobial utilization is high at RFM hospital. Identified targets for quality improvement programs include encouraging earlier switching to oral antimicrobials, reducing extended use for surgical prophylaxis and encouraging greater sensitivity testing and documentation stop dates. The development of the App appreciably reduced data collection times and analysis, and would be recommended for use in other public hospitals.</p>","PeriodicalId":35045,"journal":{"name":"Hospital practice (1995)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9148756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
期刊
Hospital practice (1995)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1